Targeting MUC16 to Reverse Anoikis Resistance: A Promising Strategy for Metastatic Lung Adenocarcinoma Therapy.

J Cancer · 2026 · PMC13105147 · PMID 42038028

Europe PMC DOI

hedged sentences

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

Among the identified candidates, MUC16 showed a highly significant association with poor overall survival (p < 0.001) and a hazard ratio (HR) of 1.04 (95% CI = 1.015-1.208), suggesting a potential role as a tumor-promoting factor.

also in 132,142 other papers

did not reach statistical significanceno p-value reported

Other variables, including age, gender, and race, did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.